CareDx Price to Book Ratio 2013-2026 | CDNA
Historical price to book ratio values for CareDx (CDNA) over the last 10 years. The current price to book ratio for CareDx as of September 16, 2026 is 6.40.
| CareDx Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 53.55 | 6.48 | |
| 2026-06-30 | 28.50 | $8.27 | 3.45 |
| 2026-03-31 | 17.36 | $6.11 | 2.84 |
| 2025-12-31 | 18.84 | $5.95 | 3.16 |
| 2025-09-30 | 14.54 | $6.05 | 2.40 |
| 2025-06-30 | 19.54 | $6.15 | 3.18 |
| 2025-03-31 | 17.75 | $6.84 | 2.60 |
| 2024-12-31 | 21.41 | $6.91 | 3.10 |
| 2024-09-30 | 31.23 | $5.15 | 6.07 |
| 2024-06-30 | 15.53 | $5.03 | 3.09 |
| 2024-03-31 | 10.59 | $4.95 | 2.14 |
| 2023-12-31 | 12.00 | $5.07 | 2.36 |
| 2023-09-30 | 7.00 | $7.28 | 0.96 |
| 2023-06-30 | 8.50 | $7.50 | 1.13 |
| 2023-03-31 | 9.14 | $7.83 | 1.17 |
| 2022-12-31 | 11.41 | $8.05 | 1.42 |
| 2022-09-30 | 17.02 | $8.16 | 2.09 |
| 2022-06-30 | 21.48 | $8.32 | 2.58 |
| 2022-03-31 | 36.99 | $8.62 | 4.29 |
| 2021-12-31 | 45.48 | $8.80 | 5.17 |
| 2021-09-30 | 63.37 | $8.95 | 7.08 |
| 2021-06-30 | 91.52 | $9.13 | 10.02 |
| 2021-03-31 | 68.09 | $9.08 | 7.50 |
| 2020-12-31 | 72.45 | $5.62 | 12.90 |
| 2020-09-30 | 37.94 | $5.47 | 6.94 |
| 2020-06-30 | 35.43 | $5.34 | 6.64 |
| 2020-03-31 | 21.83 | $2.36 | 9.26 |
| 2019-12-31 | 21.57 | $2.33 | 9.26 |
| 2019-09-30 | 22.61 | $2.30 | 9.83 |
| 2019-06-30 | 35.99 | $2.20 | 16.34 |
| 2019-03-31 | 31.52 | $2.28 | 13.82 |
| 2018-12-31 | 25.14 | $2.32 | 10.85 |
| 2018-09-30 | 28.85 | $1.14 | 25.21 |
| 2018-06-30 | 12.24 | $0.80 | 15.21 |
| 2018-03-31 | 7.97 | $0.95 | 8.41 |
| 2017-12-31 | 7.34 | $-0.21 | -35.53 |
| 2017-09-30 | 3.70 | $-0.01 | -474.36 |
| 2017-06-30 | 1.11 | $0.56 | 1.98 |
| 2017-03-31 | 1.40 | $0.70 | 2.01 |
| 2016-12-31 | 2.70 | $0.93 | 2.91 |
| 2016-09-30 | 3.55 | $1.73 | 2.05 |
| 2016-06-30 | 4.31 | $1.72 | 2.51 |
| 2016-03-31 | 4.96 | $1.71 | 2.90 |
| 2015-12-31 | 6.40 | $2.48 | 2.58 |
| 2015-09-30 | 4.17 | $2.85 | 1.46 |
| 2015-06-30 | 6.50 | $3.11 | 2.09 |
| 2015-03-31 | 5.55 | $3.34 | 1.66 |
| 2014-12-31 | 7.25 | $3.50 | 2.07 |
| 2014-09-30 | 7.00 | $3.48 | 2.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.723B | $0.380B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.177B | 25.78 |
| CVS Health (CVS) | United States | $120.850B | 12.05 |
| HCA Healthcare (HCA) | United States | $91.758B | 14.27 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.274B | 18.52 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Revvity (RVTY) | United States | $15.643B | 26.20 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| HealthEquity (HQY) | United States | $7.983B | 26.01 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |